Hypophosphatemia after high-dose iron repletion with ferric carboxymaltose and ferric derisomaltose-the randomized controlled HOMe aFers study.

导出 OA

翻译打印收藏纠错

作者： I E,Emrich ^[1] ; F,Lizzi ^[2] ; J D,Siegel ^[2] ; S,Seiler-Mussler ^[2] ; C,Ukena ^[3] ; D,Kaddu-Mulindwa ^[4] ; R,D'Amelio ^[5] ; S,Wagenpfeil ^[2] ; V M,Brandenburg ^[6] ; M,Böhm ^[7] ; D,Fliser ^[4] ; G H,Heine ^[2]

作者单位： Internal Medicine III-Cardiology, Angiology and Intensive Care Medicine, Saarland University Medical Center, Homburg, Germany. insa.emrich@uks.eu. ^[1] Internal Medicine IV-Nephrology and Hypertension, Saarland University Medical Center, Homburg, Germany. ^[2] VAUBAN Praxis Saarlouis, Saarlouis, Germany. ^[3] Internal Medicine III-Cardiology, Angiology and Intensive Care Medicine, Saarland University Medical Center, Homburg, Germany. ^[4] Internal Medicine I-Hematology and Oncology, Saarland University Medical Center, Homburg, Germany. ^[5] Institute for Medical Biometry, Epidemiology and Medical Informatics, University Medical Center, Saarland University, Campus Homburg, Homburg, Germany. ^[6] Department of Cardiology and Nephrology, Rhein-Maas Klinikum, Würselen, Germany. ^[7] Internal Medicine IV-Nephrology and Hypertension, Saarland University Medical Center, Homburg, Germany. gunnar.heine@uks.eu. ^[8] AGAPLESION MARKUS KRANKENHAUS, Frankfurt am Main, Germany. gunnar.heine@uks.eu. ^[9]

关键词 FGF23 Ferric carboxymaltose Ferric derisomaltose Hypophosphatemia Iron deficiency anemia